Bionano Genomics (BNGO) Projected to Post Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Wednesday, May 14th. Analysts expect the company to announce earnings of ($3.49) per share and revenue of $6.25 million for the quarter.

Bionano Genomics Trading Up 1.8%

NASDAQ BNGO opened at $3.91 on Tuesday. The firm has a market cap of $12.12 million, a PE ratio of -0.03 and a beta of 2.36. Bionano Genomics has a 1-year low of $2.68 and a 1-year high of $72.60. The stock has a 50-day moving average of $3.67 and a 200-day moving average of $8.85. The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07.

Analysts Set New Price Targets

Several analysts have weighed in on BNGO shares. Scotiabank boosted their price objective on Bionano Genomics from $1.00 to $4.00 and gave the company a “sector perform” rating in a research report on Wednesday, April 2nd. HC Wainwright assumed coverage on shares of Bionano Genomics in a report on Wednesday, April 9th. They set a “buy” rating and a $10.00 price target for the company.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.